RE: CX300 CLINICAL STUDY JUNE 202230 Jun 2022 14:28
On a serious note this has always been a share to trade and not hold but this is due a rise of some note now particularly with the recent director buy, if this reaches 20p+ I’m out…….markets in general across the board are dire at the moment.